Stimulation of appetite by ghrelin is regulated by leptin restraint: Peripheral and central sites of action

Journal of Nutrition

Volumn 135, Issue 5, 2005, Pages 1331-1335

  Kalra, Satya P ^a   Ueno, Naohiko ^b   Kalra, Pushpa S ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Ghrelin; Leptin; Obesity; Restraint; Rhythms

Indexed keywords

APPETITE STIMULANT; GHRELIN; LEPTIN; NEUROPEPTIDE Y;

APPETITE; CONFERENCE PAPER; ENERGY BALANCE; FEEDBACK SYSTEM; HOMEOSTASIS; HORMONE RELEASE; HUMAN; HYPOTHALAMUS; NONHUMAN; OBESITY; WEIGHT GAIN;

EID: 18344376775     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.5.1331     Document Type: Conference Paper

References (39)

1. Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L. & Kalra, P. S. (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20: 68-100.
2. Kalra, S. P., Bagnasco, M., Otukonyong, E. E., Dube, M. G. & Kalra, P. S. (2003) Rhythmic, reciprocal ghrelin and leptin signaling: new insight in the development of obesity. Regul. Pept. 111: 1-11.
3. Kalra, S. P. & Kalra, P. S. (2004) NPY: a novel on/off switch for control of appetite and reproduction. In: Neuropeptide Y and Related Peptides (Michel, M. C., ed.), pp. 221-249. Springer-Verlag, Berlin.
4. Kalra, S. P. & Kalra, P. S. (2004) Neuropeptide Y: a physiological orexigen modulated by the feedback action of ghrelin and leptin. Endocrine 22: 49-56.
5. Bagnasco, M., Kalra, P. S. & Kalra, S. P. (2002) Ghrelin and leptin pulse discharge in fed and fasted rats. Endocrinology 143: 726-729.
6. Bagnasco, M., Kalra, P. S. & Kalra, S. P. (2002) Plasma leptin levels are pulsatile in adult rats: effects of gonadectomy. Neuroendocrinology 75: 257-263.
7. Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P. & Kalra, P. S. (1991) Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl. Acad. Sci. U.S.A. 88: 10931-10935.
8. Kalra, S. P. & Kalra, P. S. (2004) NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 38: 201-211.
9. Kalra, P. S. & Kalra, S. P. (2002) Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy. In: Drugs of Today (Prous, J. R., ed.), pp. 745-757. Prous Science, Barcelona, Spain.
10. Kalra, S. P. & Kalra, P. S. (2003) Keeping obesity and metabolic syndrome at bay with central leptin and cytokine gene therapy. In: Current Medicinal Chemistry - Central Nervous System Agent (Hamilton, I., ed.), pp. 189-199. Bentham Science Publications Ltd., San Francisco, CA.
11. Dhillon, H., Ge, Y., Minter, R. M., Prima, V., Moldawer, L. L., Muzyczka, N., Zolotukhin, S., Kalra, P. S. & Kalra, S. P. (2000) Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul. Pept. 92: 97-105.
12. Ueno, N., Dube, M. G., Katz, A., Kalra, P. S. & Kalra, S. P. (2003) Leptin inhibits ghrelin-induced obesity by two distinct central and peripheral mechanisms: effects on adiponectin. 33rd Annual Society for Neuroscience Meeting, Nov. 8-12, New Orleans, LA.
13. Ueno, N., Dube, M. G., Inui, A., Kalra, P. S. & Kalra, S. P. (2004) Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 145: 4176-4184.
14. Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K. & Matsukura, S. (2001) A role for ghrelin in the central regulation of feeding. Nature 409: 194-198.
15. Tschop, M., Smiley, D. L. & Heiman, M. L. (2000) Ghrelin induces adiposity in rodents. Nature 407: 908-913.
16. Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., Strasburger, C. J., Bidlingmaier, M., Esterman, M., Heiman, M. L., Garcia-Segura, L. M., Nillni, E. A., Mendez, P., Low, M. J., Sotonyi, P., Friedman, J. M., Liu, H., Pinto, S., Colmers, W. F., Cone, R. D. & Horvath, T. L. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649-661.
17. Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E. & Weigle, D. S. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719.
18. Tschop, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E. & Heiman, M. L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707-709.
19. Crowley, W. R., Ramoz, G., Keefe, D. A., Torto, R. & Kalra, S. P. (2005) Differential effects of methamphetannine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum fed and scheduled fed rats. Neuroscience 132: 167-173.
20. Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., Suda, M., Koh, T., Natsui, K., Toyooka, S., Shirakami, G., Usui, T., Shimatsu, A., Doi, K., Hosoda, H., Kojima, M., Kangawa, K. & Nakao, K. (2001) Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J. Clin. Endocrinol. Metab. 86: 4753-4758.
21. Asakawa, A., Inui, A., Kaga, T., Katsuura, G., Fujimiya, M., Fujino, M. A. & Kasuga, M. (2003) Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52: 947-952.
22. Tschop, M., Wawarta, R., Riepl, R. L., Friedrich, S., Bidlingmaier, M., Landgraf, R. & Folwaczny, C. (2001) Post-prandial decrease of circulating human ghrelin levels. J. Endocrinol. Invest. 24: RC19-RC21.
23. Xu, B., Kalra, P. S., Farmerie, W. G. & Kalra, S. P. (1999) Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology 140: 2868-2875.
24. Otukonyong, E. E., Torto, R., Dube, M. G., Luttge, W. G., Kalra, P. S. & Kalra, S. P. (2003) Altered rhythmicity in peripheral hormonal feedback may encode dietary obesity, p. Su-81, abs. 283.10. 33rd Annual Meeting Society for Neuroscience, Nov. 8-12, New Orleans, LA.
25. Bagnasco, M., Dube, M. G., Katz, A., Kalra, P. S. & Kalra, S. P. (2003) Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes. Res. 11: 1463-1470.
26. Dhillon, H., Kalra, S. P. & Kalra, P. S. (2001) Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol. Ther. 4: 139-145.
27. Beretta, E., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2002) Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes. Pediatr. Res. 52: 189-198.
28. Bagnasco, M., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2002) Evidence for the existence of distinct central appetite and energy expenditure pathways and stimulation of ghrelin as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143: 4409-4421.
29. Dube, M. G., Beretta, E., Dhillon, H., Ueno, N., Kalra, P. S. & Kalra, S. P. (2002) Central leptin gene therapy blocks high fat diet-induced weight gain, hyperleptinemia and hyperinsulinemia: effects on serum ghrelin levels. Diabetes 51: 1729-1736.
30. Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H. & Oikawa, S. (2004) Effects of insulin, leptin, and glucagon on ghrelin secretion from isolated perfused rat stomach. Regul. Pept. 119: 77-81.
31. Horvath, T. L., Diano, S., Sotonyi, P., Heiman, M. & Tschop, M. (2001) Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology 142: 4163-4169.
32. Sahu, A., White, J. D., Kalra, P. S. & Kalra, S. P. (1992) Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. Brain Res. Mol. Brain Res. 15: 15-18.
33. Chen, H. Y., Trumbauer, M. E., Chen, A. S., Weingarth, D. T., Adams, J. R., Frazier, E. G., Shen, Z., Marsh, D. J., Feighner, S. D., Guan, X. M., Ye, Z., Nargund, R. P., Smith, R. G., Van Der Ploeg, L. H., Howard, A. D., MacNeil, D. J. & Qian, S. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP). Endocrinology 145: 2607-2612.
34. Bagnasco, M., Tulipano, G., Melis, M. R., Argiolas, A., Cocchi, D. & Muller, E. E. (2003) Endogenous ghrelin is an orexigenic peptide acting in the arcuate nucleus in response to fasting. Regul. Pept. 111: 161-167.
35. Yokosuka, M., Xu, B., Pu, S., Kalra, P. S. & Kalra, S. P. (1998) Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake. Physiol. Behav. 64: 331-338.
36. Yokosuka, M., Kalra, P. S. & Kalra, S. P. (1999) Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology 140: 4494-4500.
37. Yokosuka, M., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2001) The mPVN mediates blockade of NPY-induced feeding by a Y5 receptor antagonist: a c-FOS analysis. Peptides 22: 507-514.
38. Traebert, M., Riediger, T., Whitebread, S., Scharrer, E. & Schmid, H. A. (2002) Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J. Neuroendocrinol. 14: 580-586.
39. Pu, S., Dube, M. G., Kalra, P. S. & Kalra, S. P. (2000) Regulation of leptin secretion: Effects of aging on daily patterns of serum leptin and food consumption. Regul. Pept. 92: 107-111.